Form 8-K - Current report:
SEC Accession No. 0001104659-24-108345
Filing Date
2024-10-15
Accepted
2024-10-15 08:00:20
Documents
17
Period of Report
2024-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426107d1_8k.htm   iXBRL 8-K 36109
2 EXHIBIT 10.1 tm2426107d1_ex10-1.htm EX-10.1 22030
3 EXHIBIT 10.2 tm2426107d1_ex10-2.htm EX-10.2 21572
4 EXHIBIT 10.3 tm2426107d1_ex10-3.htm EX-10.3 21525
5 GRAPHIC logo.jpg GRAPHIC 3016
  Complete submission text file 0001104659-24-108345.txt   296449

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA prax-20241011.xsd EX-101.SCH 3036
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE prax-20241011_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prax-20241011_pre.xml EX-101.PRE 22373
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2426107d1_8k_htm.xml XML 3688
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39620 | Film No.: 241369341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)